Press Release Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones 11 hours ago
Press Release Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study 12 hours ago
Press Release Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors Aug 10
Press Release Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week Aug 6
Press Release Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Jul 30